Ultrasound-Guided Serratus Anterior Plane Block for Additional Pain Relief After Lung Surgery
Addition of Ultrasound-Guided Serratus Anterior Plane Block to an Enhanced Recovery Pathway for Thoracoscopic Lung Resection: A Randomized Trial
1 other identifier
interventional
93
1 country
6
Brief Summary
The purpose of this study is to see if an anesthesia technique called serratus anterior plane block may provide additional pain relief for the chest wall after lung surgery. The study will evaluate the effect the serratus anterior plane block technique has on the need for opioids after surgery,the level of pain during recovery, and other aspects of recovery, like whether the patient has nausea and their ability to breathe deeply. The effects of the serratus anterior plane block will be compared to the effects of an inactive (sham) block.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jan 2020
Longer than P75 for phase_2
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2020
CompletedStudy Start
First participant enrolled
January 22, 2020
CompletedFirst Posted
Study publicly available on registry
January 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2024
CompletedNovember 20, 2024
November 1, 2024
4.8 years
January 22, 2020
November 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of patients requiring opioids
Assessment of this outcome will be performed by abstracting total dosage of opioids administered during this time period from the electronic medical record (EMR). Opioid dosages will be converted to intravenous morphine sulfate equivalent.
within 24 hours post-operation
Study Arms (2)
Control Group
SHAM COMPARATORSham serratus anterior plane block plus usual car
Treatment Group
ACTIVE COMPARATORSerratus anterior plane block plus usual care
Interventions
The serratus anterior plane block will be performed by the anesthesiology team just prior to emergence from general anesthesia.
The serratus anterior plane block will be performed by the anesthesiology team just prior to emergence from general anesthesia.
Eligibility Criteria
You may qualify if:
- Adult patients ≥ 18 years of age who are capable of giving consent. English language proficiency is required.
- Undergoing elective minimally invasive (VATS or RATS) anatomic lung resection (segmentectomy or lobectomy) without an epidural.
You may not qualify if:
- Pregnancy (Patients must have a negative pregnancy test within 30 days of the operation)
- History of documented anaphylaxis or contraindication to local anesthetics
- History of ipsilateral thoracic surgery. Ipsilateral thoracic surgery indicates any previous thoracoscopic or open (i.e. via thoracotomy) pleural biopsy, lung resection, esophageal surgery, chest wall resection, or other thoracic surgery within the chest cavity. This does not include image-guided lung biopsy. Note: Mediport placement and other procedures performed by a surgeon/proceduralist NOT within the chest cavity are not excluded. Likewise, patients with a history of ipsilateral breast surgery are also not excluded. The purpose is to exclude patients who may have had injury to the intercostal nerves from previous surgery or who have surgically altered anatomy of the hemithorax.
- Patients undergoing bilateral procedures
- Weight \< 50 kg
- Chronic sustained-release opioid use for \> 2 weeks duration (in the 30 days prior to surgery)
- Significant cognitive impairment or documented psychological impairment
- American Society of Anesthesiologists (ASA) physical status \> 3
- Patients may also be excluded from the study if the block is deemed not technically feasible (this may be determined intraoperatively).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Memorial Sloan Kettering Monmouth (Consent only)
Middletown, New Jersey, 07748, United States
Memorial Sloan Kettering Bergen (Consent only )
Montvale, New Jersey, 07645, United States
Memorial Sloan Kettering Commack (Consent Only)
Commack, New York, 11725, United States
Memorial Sloan Kettering Westchester (Consent only)
Harrison, New York, 10604, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York, 10065, United States
Memorial Sloan Kettering Nassau (Consent only)
Uniondale, New York, 11553, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Jacob Jackson, MD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2020
First Posted
January 23, 2020
Study Start
January 22, 2020
Primary Completion
November 15, 2024
Study Completion
November 15, 2024
Last Updated
November 20, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org.